On a cellular level, MD has been shown to reduce neuronal density, as indicated by a decrease in NeuN-positive neurons and parvalbumin (Parv)-expressing interneurons in the prefrontal cortex (PFC) [8,9]. Here, RBFOX3 is linked to Menkes disease.